Picture loading failed.

Anti-CSF1R therapeutic antibody (Pre-made Axatilimab biosimilar,Whole mAb) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).

Axatilimab (SNDX-6352) is a high-affinity antibody targeting the colony stimulating factor 1 receptor (CSF-1R). ... Axatilimab (SNDX-6352) is a high-affinity antibody targeting the colony stimulating factor 1 receptor (CSF-1R).

Order informatioin


Delivery impact due to the Coronavirus Outbreak

With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-ab-042-1mg 1mg 3090
GMP-Bios-ab-042-10mg 10mg 21890
GMP-Bios-ab-042-100mg 100mg 148000
GMP-Bios-ab-042-xmg ≥100mg Inquiry
Shipping Cost: 760.00
Total:



Description

Products Name (INN Index) Anti-CSF1R therapeutic antibody (Pre-made Axatilimab biosimilar,Whole mAb)
INN Name Axatilimab
TargetCSF1R
FormatWhole mAb
Derivation
Species ReactivityHuman
CH1 IsotypeIgG4
VD LCKappa
Highest_Clin_Trial (Jan '20)Phase-II
Est. StatusActive
100% SI StructureNone
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2019
Year Recommended2020
CompaniesSyndax Pharmaceuticals;AstraZeneca;UCB
Conditions Approvedna
Conditions ActiveCholangiocarcinoma;Graft-versus-host disease;COVID-19
Conditions DiscontinuedSolid tumours
Development Techna